A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm

Annals of Vascular Surgery

Volumn 25, Issue 1, 2011, Pages 32-38

  Rahman, Mna Abdul ^a   Khan, Junaid Alam ^a   Mazari, Fayyaz Ali Khan ^a   Mockford, Katherine ^a   McCollum, Peter Thomas ^a   Chetter, Ian Clifford ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; GELATINASE A; GELATINASE B; NEUTROPHIL COLLAGENASE; PLACEBO; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM SURGERY; ARTERIAL WALL THICKNESS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; WALL STRESS;

AGED; AGED, 80 AND OVER; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ENGLAND; FEMALE; FINITE ELEMENT ANALYSIS; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; PLACEBO EFFECT; PREOPERATIVE CARE; PYRROLES; STRESS, MECHANICAL; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 78650510607     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2010.06.006     Document Type: Conference Paper

References (32)

1. H. Nagashima, Y. Aoka, and Y. Sakomura A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall J Vasc Surg 36 2002 158 163
2. S. Abisi, K.G. Burnand, J. Humphries, M. Waltham, P. Taylor, and A. Smith Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms Br J Surg 95 2008 333 337
3. O. Schouten, J.H. van Laanen, and E. Boersma Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth Eur J Vasc Endovasc Surg 32 2006 21 26
4. S.P. Payne, and R.B. Galland The use of a simple clinical cardiac risk index predictive of long-term outcome after infrarenal aortic reconstruction Eur J Vasc Endovasc Surg 9 1995 138 142
5. W.R. Wilson, E.C. Schwalbe, J.L. Jones, P.R. Bell, and M.M. Thompson Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm Br J Surg 92 2005 828 833
6. W.B. Keeling, P.A. Armstrong, P.A. Stone, D.F. Bandyk, and M.L. Shames An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms Vasc Endovascular Surg 39 2005 457 464
7. K. Brew, D. Dinakarpandian, and H. Nagase Tissue inhibitors of metalloproteinases: evolution, structure and function Biochim Biophys Acta 1477 2000 267 283
8. S. Anidjar, J.L. Salzmann, and D. Gentric Elastase-induced experimental aneurysms in rats Circulation 82 1990 973 981
9. B.T. Baxter, G.S. McGee, and V.P. Shively Elastin content, cross-links, and mRNA in normal and aneurysmal human aorta J Vasc Surg 16 1992 192 200
10. P.B. Dobrin, and R. Mrkvicka Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation Cardiovasc Surg 2 1994 484 488
11. T. Freestone, R.J. Turner, and A. Coady Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm Arterioscler Thromb Vasc Biol 15 1995 1145 1151
12. W.R. Wilson, J. Evans, P.R. Bell, and M.M. Thompson HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms Eur J Vasc Endovasc Surg 30 2005 259 262
13. J.K. Liao Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol Am J Cardiol 96 5A 2005 24F 33F
14. R. Sukhija, W.S. Aronow, R. Sandhu, P. Kakar, and S. Babu Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins Am J Cardiol 97 2006 279 280
15. F.J. Schlosser, M.J. Tangelder, and H.J. Verhagen Growth predictors and prognosis of small abdominal aortic aneurysms J Vasc Surg 47 2008 1127 1133
16. J. Evans, J.T. Powell, E. Schwalbe, I.M. Loftus, and M.M. Thompson Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue Eur J Vasc Endovasc Surg 34 2007 302 303
17. S. Shiraya, T. Miyake, and M. Aoki Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration Atherosclerosis 202 2009 34 40
18. M.S. Heng, M.J. Fagan, and J.W. Collier Peak wall stress measurement in elective and acute abdominal aortic aneurysms J Vasc Surg 47 2008 17 22 discussion 22
19. D.A. Vorp, M.L. Raghavan, and M.W. Webster Mechanical wall stress in abdominal aortic aneurysm: influence of diameter and asymmetry J Vasc Surg 27 1998 632 639
20. A.K. Venkatasubramaniam, M.J. Fagan, and T. Mehta A comparative study of aortic wall stress using finite element analysis for ruptured and non-ruptured abdominal aortic aneurysms Eur J Vasc Endovasc Surg 28 2004 168 176
21. M.L. Raghavan, D.A. Vorp, M.P. Federle, M.S. Makaroun, and M.W. Webster Wall stress distribution on three-dimensionally reconstructed models of human abdominal aortic aneurysm J Vasc Surg 31 2000 760 769
22. G. Ailawadi, J.L. Eliason, and G.R. Upchurch Jr. Current concepts in the pathogenesis of abdominal aortic aneurysm J Vasc Surg 38 2003 584 588
23. M.L. Raghavan, and D.A. Vorp Toward a biomechanical tool to evaluate rupture potential of abdominal aortic aneurysm: identification of a finite strain constitutive model and evaluation of its applicability J Biomech 33 2000 475 482
24. A.F. Stalenhoef The benefit of statins in non-cardiac vascular surgery patients J Vasc Surg 49 2009 260 265
25. S.M. Grundy HMG-CoA reductase inhibitors for treatment of hypercholesterolemia N Engl J Med 319 1988 24 33
26. K. Kajimoto, K. Miyauchi, and T. Kasai Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall Atherosclerosis 206 2009 505 511
27. R. Collins, R. Peto, and J. Armitage The MRC/BHF heart protection study: preliminary results Int J Clin Pract 56 2002 53 56 (Pubitemid 34100539)
28. C. Weber, W. Erl, K.S. Weber, and P.C. Weber HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia J Am Coll Cardiol 30 1997 1212 1217
29. C. Guijarro, L.M. Blanco-Colio, and M. Ortego 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture Circ Res 83 1998 490 500
30. P.J. Mateos-Caceres, and A.J. Lopez-Farre Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal aneurysms Can J Physiol Pharmacol 86 2008 431 437
31. E.F. Steinmetz, C. Buckley, and M.L. Shames Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice Ann Surg 241 2005 92 101
32. A. Kalyanasundaram, J.R. Elmore, and J.R. Manazer Simvastatin suppresses experimental aortic aneurysm expansion J Vasc Surg 43 2006 117 124